TAS-102 Plus Radiotherapy in Elderly ESCC

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 25, 2025

Primary Completion Date

September 25, 2027

Study Completion Date

December 31, 2028

Conditions
ESCCTAS 102Radiotherapy
Interventions
DRUG

TAS-102

Administered orally at 35 mg/m²/dose twice daily (morning and evening), in a bi-weekly regimen on Days 1-5.

RADIATION

Radiotherapy

Total dose of 50-60 Gy, delivered in 25-28 fractions, administered Monday through Friday (daily) until the full prescribed dose is achieved.

Trial Locations (1)

250000

The First Affiliated Hospital of Shandong First Medical University, Jinan

All Listed Sponsors
lead

Qianfoshan Hospital

OTHER

NCT07196345 - TAS-102 Plus Radiotherapy in Elderly ESCC | Biotech Hunter | Biotech Hunter